Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angeles Alvarez Secord

Showing results (151-160 of 239) with videos related to

Pageof 24
Sort By:
Cancer|November 11, 2011
A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancerAngeles Alvarez Secord, Andrew Berchuck, Robert V Higgins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancerDavid G Mutch, Mauro Orlando, Tiana Goss, et al.
Journal of Oncology Practice|January 4, 2017
Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian CancerJonathan R Foote, Micael Lopez-Acevedo, Adam H Buchanan, et al.
Gynecologic Oncology|March 4, 2014
Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patientsChelsea Zhang, Laura J Havrilesky, Gloria Broadwater, et al.
Gynecologic Oncology|May 11, 2010
A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group studyBrigitte E Miller, John A Blessing, Frederick B Stehman, et al.
International Journal of Biological Sciences|February 24, 2025
High-dose Ascorbate Exhibits Anti-proliferative and Anti-invasive Effects Dependent on PTEN/AKT/mTOR Pathway in Endometrial Cancer <i>in vitro</i> and <i>in vivo</i>Xiaochang Shen, Jiandong Wang, Weimin Kong, et al.
Gynecologic Oncology|April 2, 2019
Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancerAngeles Alvarez Secord, Michael McCollum, Brittany A Davidson, et al.
Cancers|July 2, 2021
Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial NeoplasiaAllison M Puechl, Daniel Spinosa, Andrew Berchuck, et al.
Gynecologic Oncology|October 31, 2009
Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrenceNabila Rasool, Amanda Nickles Fader, Leigh Seamon, et al.
Gynecologic Oncology|November 13, 2023
High-fat diet and obesity are associated with differential angiogenic gene expression in epithelial ovarian cancerKatherine E Baumann, Sharareh Siamakpour-Reihani, Joseph Dottino, et al.
Pageof 24

Showing results (151-160 of 239) with videos related to

Sort By:
Pageof 24
Cancer|November 11, 2011
A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancerAngeles Alvarez Secord, Andrew Berchuck, Robert V Higgins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancerDavid G Mutch, Mauro Orlando, Tiana Goss, et al.
Journal of Oncology Practice|January 4, 2017
Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian CancerJonathan R Foote, Micael Lopez-Acevedo, Adam H Buchanan, et al.
Gynecologic Oncology|March 4, 2014
Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patientsChelsea Zhang, Laura J Havrilesky, Gloria Broadwater, et al.
Gynecologic Oncology|May 11, 2010
A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group studyBrigitte E Miller, John A Blessing, Frederick B Stehman, et al.
International Journal of Biological Sciences|February 24, 2025
High-dose Ascorbate Exhibits Anti-proliferative and Anti-invasive Effects Dependent on PTEN/AKT/mTOR Pathway in Endometrial Cancer <i>in vitro</i> and <i>in vivo</i>Xiaochang Shen, Jiandong Wang, Weimin Kong, et al.
Gynecologic Oncology|April 2, 2019
Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancerAngeles Alvarez Secord, Michael McCollum, Brittany A Davidson, et al.
Cancers|July 2, 2021
Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial NeoplasiaAllison M Puechl, Daniel Spinosa, Andrew Berchuck, et al.
Gynecologic Oncology|October 31, 2009
Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrenceNabila Rasool, Amanda Nickles Fader, Leigh Seamon, et al.
Gynecologic Oncology|November 13, 2023
High-fat diet and obesity are associated with differential angiogenic gene expression in epithelial ovarian cancerKatherine E Baumann, Sharareh Siamakpour-Reihani, Joseph Dottino, et al.
Pageof 24